Comparison between Bilistick System and transcutaneous bilirubin in assessing total bilirubin serum concentration in jaundiced newborns

Objective: To compare the performance and accuracy of the JM-103 transcutaneous bilirubinometer and Bilistick System in measuring total serum bilirubin for the early identification of neonatal hyperbilirubinemia. Study Design: The study was performed on 126 consecutive term and near-term (⩾36 weeks&...

Full description

Saved in:
Bibliographic Details
Published in:Journal of perinatology 2017-09, Vol.37 (9), p.1028-1031
Main Authors: Greco, C, Iskander, I F, Akmal, D M, El Houchi, S Z, Khairy, D A, Bedogni, G, Wennberg, R P, Tiribelli, C, Coda Zabetta, C D
Format: Article
Language:English
Subjects:
692/700/139/1420
706/134
Bilirubin
Bilirubin - blood
Biomarkers - blood
Care and treatment
Children
Diagnosis
Egypt
Female
Gestational Age
Humans
Hyperbilirubinemia
Infant, Newborn
Jaundice
Jaundice, Neonatal - blood
Jaundice, Neonatal - diagnosis
Laboratories
Male
Measurement
Medical laboratories
Medicine
Medicine & Public Health
Neonatal diseases
Neonatal Screening - methods
Neonates
Newborn babies
original-article
Pediatric Surgery
Pediatrics
Physiological aspects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: To compare the performance and accuracy of the JM-103 transcutaneous bilirubinometer and Bilistick System in measuring total serum bilirubin for the early identification of neonatal hyperbilirubinemia. Study Design: The study was performed on 126 consecutive term and near-term (⩾36 weeks' gestational age) jaundiced newborns in Cairo University Children Hospital NICU, Egypt. Total serum bilirubin was assayed concurrently by the clinical laboratory and Bilistick System and estimated using the JM-103 transcutaneous bilirubin instrument. Bland–Altman analysis was used to evaluate the agreement between determinations. Result: The limits of agreement of the Bilistick System (−5.8 to 3.3 mg dl −1 ) and JM-103 system (−5.4 to 6.0 mg dl −1 ) versus the clinical laboratory results were similar. Conclusion: The Bilistick System is an accurate alternative to transcutaneous (TcB) determination for early diagnosis and proper management of the neonatal jaundice.
ISSN:0743-8346
1476-5543
DOI:10.1038/jp.2017.94